• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 5. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514

1-(Piperidin-4-yl)-1,4-diazepan-5-one (CAS No. 344779-09-5): An Overview of Its Structure, Synthesis, and Biological Applications

1-(Piperidin-4-yl)-1,4-diazepan-5-one (CAS No. 344779-09-5) is a compound that has garnered significant attention in the field of medicinal chemistry due to its unique structure and potential therapeutic applications. This compound, also known as Pipamperone, belongs to the class of piperidine derivatives and has been extensively studied for its pharmacological properties.

The molecular structure of 1-(Piperidin-4-yl)-1,4-diazepan-5-one is characterized by a piperidine ring fused with a diazepane ring, forming a complex and versatile scaffold. The presence of these rings contributes to its high chemical stability and biological activity. The compound's IUPAC name is 1-(piperidin-4-yl)-1,4-diazepan-5-one, which accurately reflects its structural composition.

In terms of synthesis, 1-(Piperidin-4-yl)-1,4-diazepan-5-one can be prepared through various methods. One common approach involves the condensation of 4-piperidone with an appropriate amine derivative, followed by cyclization to form the diazepane ring. Recent advancements in synthetic chemistry have led to the development of more efficient and scalable methods, making the compound more accessible for both research and industrial applications.

The biological activity of 1-(Piperidin-4-yl)-1,4-diazepan-5-one has been extensively investigated in various preclinical studies. It has shown promising results as a potential therapeutic agent for several neurological disorders. For instance, studies have demonstrated its ability to modulate neurotransmitter systems, particularly serotonin and dopamine receptors. This makes it a candidate for the treatment of conditions such as depression, anxiety, and schizophrenia.

In addition to its central nervous system (CNS) effects, 1-(Piperidin-4-yl)-1,4-diazepan-5-one has also been explored for its anti-inflammatory properties. Research has shown that it can inhibit the production of pro-inflammatory cytokines and reduce oxidative stress in cellular models. These findings suggest that the compound may have potential applications in the treatment of inflammatory diseases such as arthritis and multiple sclerosis.

Clinical trials are currently underway to evaluate the safety and efficacy of 1-(Piperidin-4-yl)-1,4-diazepan-5-one in human subjects. Preliminary results from phase I trials have indicated that the compound is well-tolerated at therapeutic doses with minimal side effects. These findings are encouraging and pave the way for further clinical development.

The pharmacokinetic properties of 1-(Piperidin-4-yl)-1,4-diazepan-5-one have also been studied in detail. It exhibits good oral bioavailability and a favorable pharmacokinetic profile, which are essential characteristics for a successful drug candidate. The compound is rapidly absorbed from the gastrointestinal tract and distributed throughout the body, with a half-life that allows for once-daily dosing regimens.

In conclusion, 1-(Piperidin-4-yl)-1,4-diazepan-5-one (CAS No. 344779-09-5) is a promising compound with a wide range of potential therapeutic applications. Its unique molecular structure and favorable pharmacological properties make it an attractive candidate for further research and development in the field of medicinal chemistry. As ongoing studies continue to uncover new insights into its mechanisms of action and therapeutic potential, it is likely that this compound will play an increasingly important role in the treatment of various medical conditions.

• 129323-89-3(3,7,10,13-Tetraazahexadecan-16-amide,1-amino-N-(2-aminoethyl)-10-[2-(cyclododecylamino)ethyl]-4-oxo-)
• 1465-09-4(10-methyl-3,10-diazabicyclo[4.3.1]decan-4-one)
• 79379-31-0(1-Piperazinepropanamide, N-cyclohexyl-)
• 89009-86-9(Piperidine, 1-[3-(hexahydro-1H-1,4-diazepin-1-yl)-1-oxopropyl]-)
• 88981-90-2(1-Pyrrolidinepropanamide,N-[2-(2,6-dimethyl-1-piperidinyl)ethyl]-2-oxo-, trans-)
• 956084-35-8(Pyrido[1,2-a][1,4]diazepin-3(2h)-one, octahydro-)
• 929047-08-5((9aS)-hexahydro-1H-Pyrrolo[1,2-d][1,4]diazepin-2(3H)-one)
• 1000577-67-2(Octahydropyrido[1,2-a][1,4]diazepin-5(2H)-one)
• 7415-70-5(11-methyl-4,11-diazabicyclo[4.4.1]undecan-3-one)
• 89009-81-4(1H-1,4-Diazepine-1-propanamide, N-cyclohexylhexahydro-)